1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002–2030. PLoS Med. 2006;3(11):e442.
2. Barnes PJ. New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov. 2013;12(7):543–59.
3. Droemann D, Goldmann T, Tiedje T, Zabel P, Dalhoff K, Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res. 2005;6(1):68.
4. Zhang Y, Geng S, Prasad GL, Li L. Suppression of neutrophil antimicrobial functions by total particulate matter from cigarette smoke. Front Immunol. 2018;9:2274.
5. Herr C, Beisswenger C, Hess C, Kandler K, Suttorp N, Welte T, et al. Suppression of pulmonary innate host defence in smokers. Thorax. 2009;64(2):144–9.